Clinical role of trastuzumab in metastatic breast cancer: experience of a center

This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancerObjective: To study the efficacy of different regimens of treatment based on trastuzumab in patients with Her2+ metastatic breast cancer (MBC).Ye

Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer

Poster Presentation. This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer.Trastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital.Ye